Synthesis and Bioactivity of Novel Adamantyl Derivatives as Potent MDR Reversal Agents

DOI QR Code

Barile, E.; Borriello, M.; Pietro, A. D.; Doreau, A.; Fattorusso, C.; Fattorusso, E.; Lanzotti, V. Org. Biomol. Chem. 2008, 6, 1756- 1762. https://doi.org/10.1039/b800485d
Torres-Romero, D.; Muñoz-Martínez, F.; Jimenez, I., A.; Castanys, S.; Gamarro, F.; Bazzocchi, I. L. Org. Biomol. Chem. 2009, 7, 5166-5172. https://doi.org/10.1039/b915678j
Chung, S. Y.; Sung, M. K.; Kim, N. H.; Jang, J. O.; Go, E. J.; Lee, H. J. Arch. Pharm. Res. 2005, 28, 6979-6987.
Raad, I.; Terreux, R.; Richomme, P.; Matera, E. L.; Dumontet, C.; Raynaud, J.; Guilet, D. Bioorg. Med. Chem. 2006, 14, 6979-6987. https://doi.org/10.1016/j.bmc.2006.06.026
Sivapackiam, J.; Harpstrite, S. E.; Prior, J. L.; Gu, H.; Rath, N. P.; Sharma, V. Dalton Trans. 2010, 39, 5842-5850. https://doi.org/10.1039/c002361b
Xia, Y.; Lee, K. Biomolecules & Therapeutics 2010, 18(4), 375- 385. https://doi.org/10.4062/biomolther.2010.18.4.375
Bisi, A.; Meli, M.; Gobbi, S.; Rampa, A.; Tolomeo, M.; Dusonchet, L. Bioorg. Med. Chem. Lett. 2008, 16, 6474-6482. https://doi.org/10.1016/j.bmc.2008.05.040
Coburger, C.; Wollmann, J.; Baumert, C.; Krug, M.; Molnar, J.; Lage, H.; Hilgeroth, A. J. Med. Chem. 2008, 51, 5871-5874. https://doi.org/10.1021/jm800480y
Min, K. H.; Xia, Y.; Kim, E. K.; Jin, Y.; Kaur, N.; Kim, E. S.; Kim, D. K.; Jung, H. Y.; Choi, Y.; Park, M. Y.; Min, Y. K.; Lee, K.; Lee, K. Bioorg. Med. Chem. Lett. 2009, 19, 5376-5379. https://doi.org/10.1016/j.bmcl.2009.07.127

Effects of Adamantyl Derivatives on Pharmacokinetic Behavior of Paclitaxel in Rats vol.25, pp.5, 2017, https://doi.org/10.4062/biomolther.2016.191
1,3-Bis(1,2,4-triazol-1-yl)adamantane vol.2017, pp.4, 2017, https://doi.org/10.3390/M968